The role of Ca 2+ -calmodulin stimulated protein kinase II in ischaemic stroke – A potential target for neuroprotective therapies
- 1 July 2017
- journal article
- review article
- Published by Elsevier in Neurochemistry International
- Vol. 107, 33-42
Abstract
No abstract availableKeywords
Funding Information
- Brain Foundation (G1000716)
- Hunter Medical Research Institute (HMRI 10-51)
- University of Newcastle (G0186059, 0189110, G1200673)
- National Health and Medical Research Council of Australia (AppID 55534)
This publication has 70 references indexed in Scilit:
- Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the RealityChemistry & Biology, 2014
- Loss of Calcium/Calmodulin-dependent Protein Kinase II Activity in Cortical Astrocytes Decreases Glutamate Uptake and Induces Neurotoxic Release of ATPJournal of Biological Chemistry, 2013
- Calcium/Calmodulin-dependent Protein Kinase II (CaMKII) Inhibition Induces Neurotoxicity via Dysregulation of Glutamate/Calcium Signaling and HyperexcitabilityJournal of Biological Chemistry, 2012
- Excitotoxic neuroprotection and vulnerability with CaMKII inhibitionMolecular and Cellular Neuroscience, 2011
- Apoptotic Mechanisms After Cerebral IschemiaStroke, 2009
- Spreading depolarizations occur in human ischemic stroke with high incidenceAnnals of Neurology, 2008
- Treatment of Ischemic Brain Damage by Perturbing NMDA Receptor- PSD-95 Protein InteractionsScience, 2002
- Treatment of Comatose Survivors of Out-of-Hospital Cardiac Arrest with Induced HypothermiaNew England Journal of Medicine, 2002
- Interaction with the NMDA receptor locks CaMKII in an active conformationNature, 2001
- The Multifunctional Calcium/Calmodulin-Dependent Protein Kinase: From Form to FunctionAnnual Review of Physiology, 1995